Veru Inc. (formerly known as The Female Health Company) is a medical therapeutics company, with an initial focus on the development and commercialization of pharmaceuticals for men’s and women’s health and oncology. The Company manages the Pharmaceuticals Division, which develops and commercializes pharmaceutical products for men's and women's health and oncology; and the Consumer Health and Medical Devices Division, which is focused on commercializing sexual healthcare products and devices for the consumer market, including the Company’s Female Condom for over-the-counter, and as the Female Disposable Contraceptive Device, as well as PREBOOST (benzocaine 4%) medicated individual wipes which is a male genital desensitizing drug product that helps in the prevention of premature ejaculation.

Employee Rating

4.0More
TypePublic
HQMiami, US
Founded1896
Size (employees)175 (est)+13%
Websiteveruhealthcare.com
Veru was founded in 1896 and is headquartered in Miami, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Veru Office Locations

Veru has an office in Miami
Miami, (HQ)
888 4400 Biscayne Blvd
Show all (1)
Report incorrect company information

Veru Financials and Metrics

Veru Revenue

Veru's revenue was reported to be $13.66 m in FY, 2017
USD

Revenue (Q3, 2018)

5.5m

Gross profit (Q3, 2018)

3.1m

Gross profit margin (Q3, 2018), %

55.9%

Net income (Q3, 2018)

(7.9m)

EBIT (Q3, 2018)

(5.0m)

Market capitalization (31-Aug-2018)

105.8m

Cash (30-Jun-2018)

5.6m
Veru's current market capitalization is $105.8 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

31.5m24.5m32.6m22.1m13.7m

Revenue growth, %

(32%)

Cost of goods sold

14.0m11.4m13.6m8.8m6.6m

Gross profit

17.5m13.1m19.0m13.3m7.0m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

6.7m4.3m7.9m6.7m11.0m7.8m8.2m4.8m5.6m3.2m2.4m4.3m2.6m2.6m5.5m

Cost of goods sold

3.0m2.0m3.7m2.8m4.6m3.2m2.8m1.9m2.3m1.6m1.1m2.0m1.3m1.4m2.4m

Gross profit

3.7m2.4m4.2m3.8m6.4m4.6m5.4m2.8m3.2m1.7m1.3m2.3m1.3m1.2m3.1m

Gross profit Margin, %

55%55%53%57%58%59%66%60%58%51%53%53%51%47%56%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

8.9m5.8m4.1m2.4m3.3m

Inventories

2.5m3.0m1.7m2.5m2.8m

Current Assets

16.9m13.1m21.6m18.3m10.3m

Goodwill

6.9m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

8.0m5.9m4.1m4.6m2.9m2.6m3.7m2.8m3.2m3.5m1.2m2.7m3.6m9.0m5.6m

Accounts Receivable

2.7m2.5m5.4m5.8m12.5m14.3m17.7m18.6m18.6m8.4m7.3m5.8m3.0m3.0m3.7m

Inventories

2.5m4.1m3.0m3.5m2.8m2.5m1.6m2.2m2.3m2.5m2.5m2.8m3.1m3.6m2.7m

Current Assets

16.3m15.1m14.7m14.5m19.3m20.9m23.5m24.2m25.0m15.1m11.7m12.0m10.3m16.2m12.9m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

14.3m2.4m4.3m344.7k(6.6m)

Depreciation and Amortization

556.3k589.3k494.3k422.9k334.0k

Inventories

(994.6k)(561.6k)1.1m(738.8k)(479.4k)

Accounts Payable

(871.3k)220.8k(47.5k)(376.3k)897.5k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

1.5m1.8m3.0m804.9k1.7m3.6m1.5m1.5m2.1m(1.4m)(3.1m)(3.9m)(4.3m)(8.1m)(16.0m)

Depreciation and Amortization

143.7k286.9k429.2k372.5k114.4k226.7k327.6k89.3k177.4k267.2k44.2k88.2k131.9k

Inventories

111.4k95.4k(131.7k)(299.1k)(821.1k)114.0k

Accounts Payable

1.2m1.2m1.5m931.3k1.1m1.0m1.1m(522.1k)(353.2k)127.5k853.9k775.9k
USDY, 2018

Financial Leverage

1.5 x
Show all financial metrics
Report incorrect company information

Veru News and Updates

Veru to Report Fiscal Year 2018 Financial Results, Host Conference Call on December 13th

MIAMI, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that on Thursday, December 13, 2018, the company will report financial results for the fourth quarter and fiscal year ended September 30, 2018, before the market op…

Veru to Present at Upcoming Healthcare Investor Conferences in New York

MIAMI, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that the company’s Chairman, President and Chief Executive Officer, Dr. Mitchell Steiner, will present an overview of the company’s development programs at the fol…
Report incorrect company information

Veru Company Life and Culture

Report incorrect company information

Veru Frequently Asked Questions

  • When was Veru founded?

    Veru was founded in 1896.

  • How many employees does Veru have?

    Veru has 175 employees.

  • What is Veru revenue?

    Latest Veru annual revenue is $13.7 m.

  • What is Veru revenue per employee?

    Latest Veru revenue per employee is $78 k.

  • Who are Veru competitors?

    Competitors of Veru include Sensus Healthcare, Eckert & Ziegler and Photocure.

  • Where is Veru headquarters?

    Veru headquarters is located at 888 4400 Biscayne Blvd, Miami.

  • Where are Veru offices?

    Veru has an office in Miami.

  • How many offices does Veru have?

    Veru has 1 office.